| 发明名称 |
Treatment of renal fibrosis |
| 摘要 |
The present invention relates to compositions containing quinazolinones. More particularly, the present invention relates to a composition for the treatment of renal fibrosis. This composition includes, as an active ingredient, a quinazolinone derivative such as halofurginone, which is shown herein to slow or prevent progression of renal fibrosis in vivo thereby mitigating or preventing end-stage renal failure.
|
| 申请公布号 |
US2004171627(A1) |
申请公布日期 |
2004.09.02 |
| 申请号 |
US20030723918 |
申请日期 |
2003.11.24 |
| 申请人 |
HADASIT;STATE OF ISRAEL;COLLGARD |
发明人 |
NAGLER ARNON;VLODAVSKY ISRAEL;PINES MARK;YARKONI SHAI |
| 分类号 |
A61J1/03;A61K9/08;A61K9/10;A61K9/14;A61K9/16;A61K9/20;A61K9/48;A61K31/495;A61K31/517;A61P3/10;A61P9/12;A61P13/12;A61P37/06;C07D401/06;(IPC1-7):A61K31/517 |
主分类号 |
A61J1/03 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
